PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 33185993-15 2020 This protein affects adipogenesis, metabolism of glucose and lipids as well as calcium-phosphate system by influence on the activity of fibroblast growth factors (FGF19, FGF23, FGF21). calcium phosphate 79-96 fibroblast growth factor 23 Homo sapiens 170-175 32386861-1 2020 BACKGROUND & AIMS: Abnormalities of parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) secretion may cause calcium-phosphate (Ca-P) metabolism disorders in nephrolithiasis. calcium phosphate 122-139 fibroblast growth factor 23 Homo sapiens 66-93 32386861-1 2020 BACKGROUND & AIMS: Abnormalities of parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) secretion may cause calcium-phosphate (Ca-P) metabolism disorders in nephrolithiasis. calcium phosphate 122-139 fibroblast growth factor 23 Homo sapiens 95-100 32386861-1 2020 BACKGROUND & AIMS: Abnormalities of parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) secretion may cause calcium-phosphate (Ca-P) metabolism disorders in nephrolithiasis. calcium phosphate 141-145 fibroblast growth factor 23 Homo sapiens 66-93 32386861-1 2020 BACKGROUND & AIMS: Abnormalities of parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) secretion may cause calcium-phosphate (Ca-P) metabolism disorders in nephrolithiasis. calcium phosphate 141-145 fibroblast growth factor 23 Homo sapiens 95-100 24111496-1 2014 OBJECTIVE: Recent clinical studies suggest that fibroblast growth factor 23 (FGF23) is important in the pathogenesis of calcium-phosphate abnormalities in patients with chronic kidney disease and that increased plasma FGF23 concentration is a cardiovascular risk factor in these patients. calcium phosphate 120-137 fibroblast growth factor 23 Homo sapiens 48-75 31942755-1 2020 BACKGROUND AND PURPOSE: Fibroblast growth factor 23 (FGF23) is associated with atherosclerosis via nitric-oxide-associated endothelial dysfunction and calcium-phosphate-related bone mineralization. calcium phosphate 151-168 fibroblast growth factor 23 Homo sapiens 24-51 31942755-1 2020 BACKGROUND AND PURPOSE: Fibroblast growth factor 23 (FGF23) is associated with atherosclerosis via nitric-oxide-associated endothelial dysfunction and calcium-phosphate-related bone mineralization. calcium phosphate 151-168 fibroblast growth factor 23 Homo sapiens 53-58 24111496-1 2014 OBJECTIVE: Recent clinical studies suggest that fibroblast growth factor 23 (FGF23) is important in the pathogenesis of calcium-phosphate abnormalities in patients with chronic kidney disease and that increased plasma FGF23 concentration is a cardiovascular risk factor in these patients. calcium phosphate 120-137 fibroblast growth factor 23 Homo sapiens 77-82 21733911-0 2011 The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation. calcium phosphate 51-68 fibroblast growth factor 23 Homo sapiens 17-44 23490272-1 2013 This study was aimed to explore the role of serum fibroblast growth factor (FGF)-23, matrix Gla protein (MGP) and fetuin-A in the calcium-phosphate metabolism and their predicting value in coronary artery calcification in maintenance hemodialysis (MHD) patients. calcium phosphate 130-147 fibroblast growth factor 23 Homo sapiens 50-83 24039882-7 2013 CONCLUSIONS: In cardiology department inpatients, circulating FGF23 concentrations were found to be associated with the left ventricular mass and LVEF independent of renal function and other calcium-phosphate metabolism-related parameters. calcium phosphate 191-208 fibroblast growth factor 23 Homo sapiens 62-67 23413976-2 2013 We aimed to describe the effect of the calcium phosphate product (Ca*P) on FGF-23 concentrations in children and young adults without confounding cardiovascular disease. calcium phosphate 39-56 fibroblast growth factor 23 Homo sapiens 75-81 22554017-12 2012 FGF23 is increased in children after PRT, especially in patients with chronic allograft dysfunction, and seems to be a more sensitive marker of dysregulated calcium phosphate homeostasis than PTH. calcium phosphate 157-174 fibroblast growth factor 23 Homo sapiens 0-5 23214203-12 2012 There is ambiguous data if FGF-23 only reflects disturbances in calcium-phosphate metabolism or if it exerts a detrimental effect itself by diminishing calcitriol synthesis, inducing cell proliferation or acting through low-affinity, Klotho-independent receptors in the heart and endothelium. calcium phosphate 64-81 fibroblast growth factor 23 Homo sapiens 27-33 22164160-1 2011 Plasma FGF-23 concentrations and its relationship with calcium-phosphate homeostasis were evaluated in 48 perimenopausal obese women and in 29 nonobese controls. calcium phosphate 55-72 fibroblast growth factor 23 Homo sapiens 7-13 15086938-9 2004 Our results may provide new insights into the pathophysiologic effects of FGF-23 on calcium-phosphate homeostasis. calcium phosphate 84-101 fibroblast growth factor 23 Homo sapiens 74-80 22010474-5 2011 In the 2nd part of this work, regulatory activity in the calcium-phosphate homeostasis in different stages of chronic kidney disease (CKD) with special attention to increased synthesis of FGF-23 in the course of declined glomerular filtration rate were elucidated. calcium phosphate 57-74 fibroblast growth factor 23 Homo sapiens 188-194 20376517-9 2010 Factors affecting log(10)FGF-23 included the serum calcium phosphate product (beta = 0.603) and K (t)/V (integrated fractional clearance expressed per dialysis, beta = -0.244). calcium phosphate 51-68 fibroblast growth factor 23 Homo sapiens 25-31 20376517-12 2010 The only factors affecting log(10)FGF-23 were the serum calcium phosphate product and K (t)/V. calcium phosphate 56-73 fibroblast growth factor 23 Homo sapiens 34-40 19946326-1 2009 Fibroblast growth factor (FGF)-23 is a recently discovered regulator of calcium-phosphate metabolism. calcium phosphate 72-89 fibroblast growth factor 23 Homo sapiens 0-33 19946326-5 2009 However, in cross-sectional studies increased FGF-23 levels in patients with CKD were found to be associated not only with therapy-resistant secondary hyperparathyroidism but were also independently related to myocardial hypertrophy and endothelial dysfunction after adjustment for traditional markers of calcium-phosphate metabolism. calcium phosphate 305-322 fibroblast growth factor 23 Homo sapiens 46-52 18791804-14 2008 CONCLUSION: Our findings indicate that the plasma FGF-23 level is associated with calcium-phosphate metabolism disorders, but not with aortic calcification, in both non-DM and DM patients on chronic HD. calcium phosphate 82-99 fibroblast growth factor 23 Homo sapiens 50-56 22335012-6 2011 The current knowledge on FGF-23 has lead to suspect that in the nearest future it may serve as sensitive marker of early calcium-phosphate disturbances in patients with CKD. calcium phosphate 121-138 fibroblast growth factor 23 Homo sapiens 25-31 21234310-1 2010 Fibroblast growth factor- (FGF-)23 is a recently discovered regulator of calcium-phosphate metabolism. calcium phosphate 73-90 fibroblast growth factor 23 Homo sapiens 0-34 19188744-0 2009 Familial tumoral calcinosis caused by a novel FGF23 mutation: response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer. calcium phosphate 141-158 fibroblast growth factor 23 Homo sapiens 46-51 33776565-0 2021 FGF23, alpha-Klotho and vitamin D mediated calcium-phosphate metabolism in haemodialysis patients. calcium phosphate 43-60 fibroblast growth factor 23 Homo sapiens 0-5 25583093-2 2015 OBJECTIVE: Fibroblast growth factor 23 (FGF23) is a phosphaturic agent involved in calcium-phosphate homeostasis. calcium phosphate 83-100 fibroblast growth factor 23 Homo sapiens 11-38 25583093-2 2015 OBJECTIVE: Fibroblast growth factor 23 (FGF23) is a phosphaturic agent involved in calcium-phosphate homeostasis. calcium phosphate 83-100 fibroblast growth factor 23 Homo sapiens 40-45 34300255-12 2021 On the other hand, FGF-23 can represent a parameter reflecting the degree of calcium-phosphate imbalance in PHPT patients, but its usefulness in monitoring the effects of PTX requires further research. calcium phosphate 77-94 fibroblast growth factor 23 Homo sapiens 19-25